Maya Williams

High Impact

Assistant Professor

UAMS

Last publication 2025 Last refreshed 2026-05-16

faculty

30 h-index 139 pubs 3,322 cited

Research Areas

Links

ORCID Lab Website

OverviewAI-generated summary

Maya Williams is an Assistant Professor at the University of Arkansas for Medical Sciences. Her scholarly work encompasses a range of topics, including reviews of medical literature, case reports, and studies on vaccine immunogenicity and treatment outcomes in various conditions. She has co-authored publications investigating the immunogenicity of inactivated SARS-CoV-2 vaccines and novel polysaccharide-based adjuvants for dengue vaccines in mice. Additionally, her research has explored treatment outcomes for cats undergoing splenectomy and patient-reported well-being and functional assessments in multiple sclerosis patients receiving fampridine treatment.

Williams' research also extends to educational and social issues. She has contributed to a scoping review on colorism in schools, examining the academic, social, and emotional experiences of students of color. She has also investigated teacher perspectives on restorative practice implementation in schools, identifying programmatic elements that promote positive relational development. Her publication record includes 139 total publications with 3,308 citations and an h-index of 30, designating her as a highly cited researcher. She actively collaborates with researchers at the University of Arkansas for Medical Sciences, including H. Williams and James W. Williams, with whom she shares 12 co-authored publications.

Metrics

h-index: 30
Publications: 139
Citations: 3,322

Selected Publications

Consultant perception of the feasibility and effectiveness of infant and early childhood mental health consultation services provided virtually to early care and education (2025)

DOI OpenAlex
A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i> (2025)

2 citations DOI OpenAlex
A peptide-based human papillomavirus therapeutic vaccine, PepCan, or <i>Candida</i> adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3). (2023)

2 citations DOI OpenAlex
HPV-associated Vulvar Intraepithelial Carcinoma With Sebaceous Differentiation: Report of 2 Cases (2022)

4 citations DOI OpenAlex
Comparison of Chloroprocaine Versus Lidocaine With Epinephrine, Sodium Bicarbonate, and Fentanyl for Epidural Extension Anesthesia in Elective Cesarean Delivery: A Randomized, Triple-blind, Noninferiority Study (2022)

1 citation DOI OpenAlex